Thursday, September 05, 2019 1:43:19 PM
I searched google a bit in regards to Kevin Duffy.
Oddly, I did not find much info about him online, such as his involvement with Merck and Keytruda etc. Anyone else find some links?
Of course we already had become aware of this website for Kevin Duffy:
https://www.linkedin.com/in/kevin-duffy-9519831/
Curiously, there is another Linkedin page for a Kevin Duffy in the UK:
www.linkedin.com/in/kevin-duffy-5771bb155/?originalSubdomain=uk
this includes:
Galderma UK Ltd
Product & Brand Manager
Dates Employed Oct 2010 – Apr 2018
Employment Duration 7 yrs 7 mos
And the first Linkedin link shows
Galderma
Medical Science Liaison
Dates Employed Mar 2008 – Nov 2011
Employment Duration 3 yrs 9 mos
Both links show Dermatology as one of the Specialties/Skills.
What a coincidence.
Oddly, I did not find much info about him online, such as his involvement with Merck and Keytruda etc. Anyone else find some links?
Of course we already had become aware of this website for Kevin Duffy:
https://www.linkedin.com/in/kevin-duffy-9519831/
Curiously, there is another Linkedin page for a Kevin Duffy in the UK:
www.linkedin.com/in/kevin-duffy-5771bb155/?originalSubdomain=uk
this includes:
Galderma UK Ltd
Product & Brand Manager
Dates Employed Oct 2010 – Apr 2018
Employment Duration 7 yrs 7 mos
And the first Linkedin link shows
Galderma
Medical Science Liaison
Dates Employed Mar 2008 – Nov 2011
Employment Duration 3 yrs 9 mos
Both links show Dermatology as one of the Specialties/Skills.
What a coincidence.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
